Arrowpoint Investment Partners (Singapore) Pte. Ltd. Vertex Pharmaceuticals Inc Transaction History
Arrowpoint Investment Partners (Singapore) Pte. Ltd.
- $487 Billion
- Q4 2024
A detailed history of Arrowpoint Investment Partners (Singapore) Pte. Ltd. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds 4,600 shares of VRTX stock, worth $2.23 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
4,600Holding current value
$2.23 Million% of portfolio
0.38%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VRTX
# of Institutions
1,753Shares Held
227MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13.7 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.3 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.3 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.8 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.05 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $124B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...